May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
The Effect of Selective Laser Trabeculoplasty on Intraocular Pressure in Patients With Steroid–Induced Ocular Hypertension
Author Affiliations & Notes
  • A.J. Taglienti
    Ophthalmology, Mount Sinai School of Medicine, New York, NY
  • B. Rubin
    Ophthalmology, Mount Sinai School of Medicine, New York, NY
  • R. Rothman
    Glaucoma Consultants of Long Island, Great Neck, NY
  • C. Marcus
    Glaucoma Consultants of Long Island, Great Neck, NY
  • J.B. Serle
    Ophthalmology, Mount Sinai School of Medicine, New York, NY
  • Footnotes
    Commercial Relationships  A.J. Taglienti, None; B. Rubin, None; R. Rothman, None; C. Marcus, None; J.B. Serle, None.
  • Footnotes
    Support  NEI EY01867 , RPB, The Fund for Ophthalmic Knowledge
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 121. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.J. Taglienti, B. Rubin, R. Rothman, C. Marcus, J.B. Serle; The Effect of Selective Laser Trabeculoplasty on Intraocular Pressure in Patients With Steroid–Induced Ocular Hypertension . Invest. Ophthalmol. Vis. Sci. 2005;46(13):121.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To assess the effectiveness of Selective Laser Trabeculoplasty (SLT) in lowering intraocular pressure (IOP) in patients with steroid–induced ocular hypertension. Methods:A retrospective review was performed on six patients (6 eyes) with IOP elevation following intravitreal triamcinolone acetonide (4.0 mg/ 0.1 ml) injections for macular edema (5 patients) or central retinal vein occlusion (1 patient). Two patients had preexisting open angle glaucoma and one patient had preexisting ocular hypertension. The time between intraocular corticosteroid injection and subsequent ocular hypertension ranged from 5 to 24 weeks. Following unsuccessful maximum tolerated medical therapy, patients underwent an SLT in one eye between April 2003 and October 2004. IOP was measured at 4 wks pre–laser, just prior to laser, and at 1 hr, 1 wk, 1 month and 3 months post–laser. Intraocular pressures at these different time points were compared using a two–tailed t–test and Repeated Measures (RM) ANOVA. Results:Six patients were on a mean of 3.1 (± 0.8) ocular hypotensive medications prior to the SLT. Mean IOP±SD decreased following SLT from 39.7±7.1 mmHg pre–op, to 25.3±7.8 mmHg at 1 wk post–op (p<0.02), and 26.5±9.4 mmHg at 1 month post–op (p<0.025), and 24.8±11.3 mmHg at 3 months post–op IOP (p< 0.02). One patient underwent two SLT procedures, the second was 2 wks after initial SLT, and one patient underwent a second SLT after the 3 month post–laser visit. IOP in the fellow eyes of all patients was unchanged (p>0.2, RM ANOVA). Conclusions:SLT lowers IOP in patients with steroid–induced ocular hypertension. Repeat SLT treatments may be necessary. SLT is a temporizing procedure to consider in patients with steroid–induced ocular hypertension.

Keywords: intraocular pressure • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×